Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “a Randomized Double-blind Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04208178
What this trial is testing

Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Who this might be right for
Advanced HER2+Breast Cancer
Novartis Pharmaceuticals 19
Not applicableStudy completedNCT05794685
What this trial is testing

The Analgesic Efficacy of Ultrasound Guided Adductor Canal Block Versus 4 in 1 Block in Patients Undergoing Knee Surgeries: A Comparative Randomized Double Blinded Study .

Who this might be right for
Comparing the Analgesic Outcome by ( 4 in 1 Block ) & ( Adductor Canal Block )
Mahmoud Hussein Bahr 40
Testing effectiveness (Phase 2)UnknownNCT02139085
What this trial is testing

Great Saphenous Vein Electrocoagulation

Who this might be right for
Venous DiseaseVaricose Veins
Instituto Dante Pazzanese de Cardiologia 82
Testing effectiveness (Phase 2)Study completedNCT01392963
What this trial is testing

The Treatment of Depression With Botulinum Type A Toxin

Who this might be right for
Depression
Seton Healthcare Family 30
Large-scale testing (Phase 3)Study completedNCT00134563
What this trial is testing

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,088
Early research (Phase 1)Study completedNCT06147921
What this trial is testing

Phase 1, SAD/MAD of Verasone™ Administered by Sinonasal Irrigation in Healthy Participants

Who this might be right for
Healthy Volunteers
Diceros Therapeutics 46
Large-scale testing (Phase 3)Study completedNCT00564421
What this trial is testing

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

Who this might be right for
Seasonal Allergic Rhinitis
Merck Sharp & Dohme LLC 798
Large-scale testing (Phase 3)UnknownNCT06293716
What this trial is testing

CVL237 Tablets for APDS/PASLI

Who this might be right for
PI3K and P110delta Hyperactivation Syndrome
Convalife (Shanghai) Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT00139906
What this trial is testing

Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00509106
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 622
Large-scale testing (Phase 3)Study completedNCT05306704
What this trial is testing

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Who this might be right for
HIV-1-infectionHypovitaminosis D
University of the Punjab 95
Testing effectiveness (Phase 2)Study completedNCT05774184
What this trial is testing

CDX-0159 in Patients With Eosinophilic Esophagitis

Who this might be right for
Eosinophilic Esophagitis
Celldex Therapeutics 86
Not applicableUnknownNCT03558347
What this trial is testing

CF41102 5-year Clinical Evaluation of Conelog® Implant With 7 mm Length

Who this might be right for
Dental ImplantsPartial Edentulism
RWTH Aachen University 20
Not applicableLooking for participantsNCT06966778
What this trial is testing

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Who this might be right for
Localized Prostate CancerPostoperative Urinary Incontinence
National Taiwan University Hospital 135
Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07644247
What this trial is testing

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

Who this might be right for
LVAD (Left Ventricular Assist Device) ThrombosisLVADLVAD (Left Ventricular Assist Device)+9 more
China National Center for Cardiovascular Diseases 370
Post-approval studies (Phase 4)Study completedNCT03536455
What this trial is testing

Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude

Who this might be right for
Altitude Hypoxia
University of Zurich 92
Not applicableStudy completedNCT07235826
What this trial is testing

Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children

Who this might be right for
Recurrent Tonsillitis
Liaquat University of Medical & Health Sciences 216
Testing effectiveness (Phase 2)Study completedNCT00631878
What this trial is testing

Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110

Who this might be right for
Neonatal Staphylococcal Sepsis
Biosynexus Incorporated 53
Large-scale testing (Phase 3)Study completedNCT01811485
What this trial is testing

Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 171
Next Page